Plasma D-dimer and prothrombin fragment 1+2 in evaluating the occurrence of venous thromboembolism in advanced cancer patients and the effect of preventive anticoagulant therapy

DD and PF1+2 are reliable indicators for assessing VTE risk in advanced cancer patients and can help guide the use of preventive anticoagulant therapy.

Authors

Institutions

Publication Details

Journal
Journal of Medical Biochemistry
Published
2025-01-01
DOI
https://doi.org/10.5937/jomb0-55897
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma D-dimer and prothrombin fragment 1+2 in evaluating the occurrence of venous thromboembolism in advanced cancer patients and the effect of preventive anticoagulant therapy

Baiping Zhang, Chang Wen Ke, Huiying Fu, Yongchun Xu et al.
Journal of Medical Biochemistry
Venous Thromboembolism Diagnosis and Management
article

Plasma D-dimer and prothrombin fragment 1+2 in evaluating the occurrence of venous thromboembolism in advanced cancer patients and the effect of preventive anticoagulant therapy

Baiping Zhang, Chang Wen Ke, Huiying Fu, Yongchun Xu, Ying Zhong
article en

Abstract

DD and PF1+2 are reliable indicators for assessing VTE risk in advanced cancer patients and can help guide the use of preventive anticoagulant therapy.

Journal of Medical BiochemistryVol. 44(6)
People's Liberation Army 401 Hospital (CN)
Openalex Percentile: Top 85%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.